Glanbia (GLAPF) has released an update.
Glanbia plc, a leader in nutrition, has made a significant move in the stock market by purchasing 37,000 of its own ordinary shares on Euronext Dublin, with prices ranging between €15.23 and €15.31 per share, as part of a larger €50 million buy-back program set to run until December 19, 2024. This transaction, which is part of a previously announced initiative, will result in the reduction of Glanbia’s issued ordinary shares to 260,254,859 following the cancellation of the purchased shares.
For further insights into GLAPF stock, check out TipRanks’ Stock Analysis page.